Target intelligence / Profile preview

Spider Venom Components (N/A)

Target
N/A
Molecular classification
Peptide toxins, Enzymes, Small molecular mass compounds, Antimicrobial peptides, Neurotoxins
01

Overview

Spider venom is a complex mixture of bioactive molecules, including small molecular mass compounds, antimicrobial peptides, cysteine-rich peptide neurotoxins, and proteins/enzymes like phospholipases and proteases. These components target neuronal or neuromuscular signal transduction systems, with key targets including voltage-gated ion channels (NaV, CaV, KCa), lipid bilayers, and NMDA receptors. Venom components exhibit diverse biological activities, such as neurotoxic effects, antimicrobial properties, and insect-selective toxicity. Many spider venom peptides display potent pharmacological activities, rendering them valuable resources for potential therapeutic candidates.

Other names
Spider venom toxinsSpider venom peptidesSpider venom enzymesSpider venom neurotoxins
02

Mechanism of action

Modulation of ion channel gating, disruption of membrane integrity, enzymatic degradation of phospholipids and extracellular matrix, receptor binding

03

Biological functions

Neurotransmission modulationIon channel regulationMembrane disruptionEnzymatic hydrolysisAntimicrobial activityPrey immobilizationDefense mechanism
04

Disease associations

Pain (potential analgesic)Infection (potential antimicrobial)Cancer (potential cytotoxic)
05

Safety considerations

ToxicityOff-target effectsImmunogenicity
06

Interacting drugs

None (potential source for novel therapeutics)

Beyond the preview

Go deeper on Spider Venom Components (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spider Venom Components (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call